FDA Inspection
Medpace IncMedpace Inc – FDA Inspection, Jun 16, 2017
Record Details
This FDA Inspection record concerns Medpace Inc, with an inspection on June 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8969333d-175e-4728-9c58-9cca27393ec9
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1017674
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Medpace Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Cincinnati District Office | |
| February 13, 2025 | Not classified | Cincinnati District Office | |
| July 11, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 26, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Medpace Inc
- FDA Inspection 1332930 - 2026-07-31
- FDA Inspection 1263213 - 2025-02-13
- FDA Inspection 1245618 - 2024-07-11
- FDA Inspection 1232744 - 2024-03-06
- FDA Inspection 1169068 - 2022-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.